224
Participants
Start Date
January 29, 2024
Primary Completion Date
November 20, 2024
Study Completion Date
February 10, 2025
Meloxicam Injection
Intravenous meloxicam Injection, 30mg every 24 hours, for a total of 2 doses
Sodium Chloride Injection
Intravenous Sodium Chloride Injection, 18mg every 24 hours, for a total of 2 doses
Cangzhou People's Hospital, Cangzhou
The Third Xiangya Hospital Of Central South University, Changsha
Heping Hospital Affiliated To Changzhi Medical College, Changzhi
Sichuan Academy of Medical Sciengces & Sichuan Provincial People's Hospital, Chengdu
The Second People's Hospital Of Chengdu, Chengdu
The Third People's Hospital Of Chengdu, Chengdu
The First People's Hospital Of Guangyuan, Guangyuan
The First affiliated Hospital Of Jinan University, Guangzhou
The Affiliated Hospital Of Guizhou Medical University, Guizhou
Haikou People's Hospital, Haikou
The Second Hospital Of Anhui Medical University, Hefei
The First Affiliated Hospital Of University Of South ChinaThe First Affiliated Hospital Of University Of South China, Hengyang
Meihekou Central Hospital, Meihekou
Nanjing Women and Children's Healthcare Hospital, Nanjing
The Second Nanning People's Hospital, Nanning
Ningbo Medical Center Lihuili Hospital, Ningbo
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou
The First Affiliated Hospital Of Xi'an Medical University, Xi'an
Yangtze River Pharmaceutical Group Co., Ltd.
INDUSTRY